Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). (Image courtesy of Nyxoah webpage)
REGULATED INFORMATION
Publication relating to transparency notifications
Mont-Saint-Guibert, Belgium, Nov. 18 (Korea Bizwire) – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received a transparency notification as detailed below.
On November 15, 2024, Nyxoah received a transparency notification from ResMed Inc. following the passive crossing of a threshold. Based on the notification, ResMed Inc. holds 1,727,864 voting rights, representing 4.62% of the total number of voting rights on October 9, 2024 (37,389,015).
The notification dated November 5, 2024 contains the following information:
- Reason for the notification: passive crossing of a threshold
- Notification by: a person that notifies alone
- Persons subject to the notification requirement:Date on which the threshold was crossed: October 9, 2024
- ResMed Inc. (with address at 9001 Spectrum Center Boulevard, San Diego, CA 92123, USA)
- Threshold that is crossed: 5%
- Denominator: 37,389,015
- Notified details:
| A) Voting rights | Previous notification | After the transaction | |||
| # of voting rights | # of voting rights | % of voting rights | |||
| Holders of voting rights | Linked to securities | Not linked to the securities | Linked to securities | Not linked to the securities | |
| ResMed Inc. | 1,619,756 | 1,727,864 | |||
| TOTAL | 1,727,864 | 0 | 4.62% | 0.00% | |
- Full chain of controlled undertakings through which the holding is effectively held: No indirect holding of voting securities. ResMed Inc. is not a controlled entity.
*
* *
Contact:
Nyxoah
John Landry, CFO
IR@nyxoah.com
Attachment
Source: Nyxoah via GLOBE NEWSWIRE
